| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |